+

WO2018163564A1 - Cathéter - Google Patents

Cathéter Download PDF

Info

Publication number
WO2018163564A1
WO2018163564A1 PCT/JP2017/045986 JP2017045986W WO2018163564A1 WO 2018163564 A1 WO2018163564 A1 WO 2018163564A1 JP 2017045986 W JP2017045986 W JP 2017045986W WO 2018163564 A1 WO2018163564 A1 WO 2018163564A1
Authority
WO
WIPO (PCT)
Prior art keywords
marker
catheter
distal end
outer diameter
disposed
Prior art date
Application number
PCT/JP2017/045986
Other languages
English (en)
Japanese (ja)
Inventor
太陽 山下
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Publication of WO2018163564A1 publication Critical patent/WO2018163564A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes

Definitions

  • the present invention relates to a catheter.
  • catheters have been used to treat and diagnose lesions in living body lumens.
  • the surgeon inserts the catheter into the living body lumen and arranges the distal end portion of the catheter at the lesion site as the target site to treat or diagnose the lesion site.
  • Patent Document 1 discloses a catheter having a ring-shaped marker portion having radiopacity at the distal end portion. When the operator confirms the position of the marker portion under radioscopy, it becomes easy to position the distal end portion of the catheter at or near the lesioned portion.
  • the marker portion is made of a relatively rigid material such as metal. For this reason, as shown in Patent Document 1 below, the marker portion is disposed at a position spaced from the most distal end of the catheter to the proximal end side, and a soft resin is disposed on the distal end side to ensure safety with respect to the living body lumen. Yes.
  • the marker portion is disposed at a position spaced from the most distal end of the catheter toward the proximal end side, the most distal position of the catheter cannot be accurately grasped under radioscopy.
  • the portion where the marker portion having relatively high rigidity is arranged in the catheter and the vicinity thereof have high rigidity. Thereby, the flexibility (easy to bend) of the distal end portion of the catheter is reduced, and the safety may be lowered.
  • the present invention has been made to solve the above-described problems, and provides a catheter capable of improving the state-of-the-art visibility of a catheter under radioscopy while ensuring the safety of the catheter. Objective.
  • the catheter according to the present invention includes a tubular shaft portion having a distal end portion formed of a resin, a ring-shaped marker portion disposed at the distal end portion of the shaft portion and formed of a radiopaque metal,
  • a catheter having The distal end portion of the shaft portion includes a tapered portion formed in a tapered shape including the most distal end and an outer diameter of the shaft portion tapering toward the distal end side, and is disposed closer to the proximal end side than the tapered portion, and is axially And a constant outer diameter portion having a substantially constant outer diameter.
  • the marker part has a marker tip part arranged at the taper part so as to follow the outer shape of the taper part, and a marker base end part arranged at the constant outer diameter part.
  • the first region constituted by the tapered portion and the marker tip end portion has a higher resin content per unit volume than the second region constituted by the constant outer diameter portion and the marker base end portion.
  • the tip of the marker is arranged so as to follow the outer shape of the tapered portion, by observing the marker portion under radioscopy, the most advanced position of the catheter can be improved. Accurately grasp. Further, since the first region is formed with a higher resin content per unit volume than the second region, the most advanced rigidity of the catheter can be reduced. Moreover, since the marker part can be arranged on the distal end side of the catheter with the above configuration, the starting point of the bending of the catheter can be further on the distal end side. Thereby, the bendability (flexibility) of the distal end portion of the catheter can be improved. Therefore, according to the catheter, the most advanced visibility of the catheter under radioscopy can be improved while ensuring the safety of the catheter.
  • FIG. 8A is a diagram showing a schematic configuration of a catheter abutment test
  • FIG. 8B is a diagram showing a schematic configuration of a catheter abutment test
  • FIG. 8B is a diagram showing a state of the catheter according to the embodiment and the comparison in the abutment test. It is a side view of the marker part which concerns on the modification 1 of this invention. It is a side view of the marker part which concerns on the modification 2 of this invention.
  • FIG. 11A is a side view of a marker portion according to the third modification of the present invention
  • FIG. 11B is an axial sectional view of the marker portion according to the third modification. It is a side view of the marker part which concerns on the modification of this invention. It is a side view of the marker part which concerns on the modification of this invention. It is a side view of the marker part which concerns on the modification of this invention. It is a side view of the marker part which concerns on the modification of this invention. It is a side view of the marker part which concerns on the modification of this invention. It is a side view of the marker part which concerns on the modification of this invention. It is a side view of the marker part which concerns on the modification of this invention. It is
  • FIG. 1 is a schematic view showing a catheter 100
  • FIGS. 2 and 3 are enlarged side views and axial sectional views showing a distal end portion of the catheter 100
  • FIGS. 4 and 5 are side views and perspective views of a marker portion.
  • FIG. 1 is a schematic view showing a catheter 100
  • FIGS. 2 and 3 are enlarged side views and axial sectional views showing a distal end portion of the catheter 100
  • FIGS. 4 and 5 are side views and perspective views of a marker portion.
  • FIG. 1 is a schematic view showing a catheter 100
  • FIGS. 2 and 3 are enlarged side views and axial sectional views showing a distal end portion of the catheter 100
  • FIGS. 4 and 5 are side views and perspective views of a marker portion.
  • FIG. 1 is a schematic view showing a catheter 100
  • FIGS. 2 and 3 are enlarged side views and axial sectional views showing a distal end portion of the catheter 100
  • FIGS. 4 and 5 are side views and perspective views of
  • the catheter 100 is a microcatheter used for supplying a drug or a contrast medium to a lesioned part.
  • the catheter 100 is used, for example, for transcatheter arterial chemoembolization (TACE).
  • TACE transcatheter arterial chemoembolization
  • Hepatic artery chemoembolization is a treatment method in which a catheter is advanced from the liver artery further to the vicinity of the tumor, and an anticancer agent or embolic material is injected to selectively necrotize the tumor.
  • the catheter 100 will be outlined with reference to FIGS.
  • the catheter 100 has a distal end portion 110d formed of resin, a tubular shaft portion 110 that can be introduced into a living body, and a ring shape that is disposed on the distal end portion 110d of the shaft portion 110 and is formed of a radiopaque metal.
  • the marker portion 120 and the catheter hub 130 connected to the proximal end portion of the shaft portion 110 are included.
  • the catheter 100 has a kink protector (strain relief) 135 in the vicinity of the connecting portion between the shaft portion 110 and the catheter hub 130.
  • the catheter 100 is not limited to the configuration shown in FIG. 1 and may not include the kink protector 135.
  • the catheter 100 has a contrast region A having radiopacity due to the arrangement of the marker portion 120.
  • the contrast area A has a first area A1 including the most distal end, and a second area A2 disposed on the proximal side of the first area A1. Details of the contrast region A will be described later.
  • the longitudinal direction (left-right direction in FIG. 1) in which the shaft portion 110 of the catheter 100 extends is defined as the axial direction, and is indicated by an arrow X in each figure.
  • a direction orthogonal to the axial direction is defined as a radial direction and is indicated by an arrow R.
  • the side to be inserted into the living body (intravascular) in the catheter 100 is defined as the tip side (distal side, left side in FIG. 1), and is indicated by an arrow X1 in each figure and is located on the side opposite to the tip side.
  • the side on which the above operations are performed is defined as a proximal side (proximal side, right side in FIG. 1), and is indicated by an arrow X2 in each figure.
  • the “leading end of the catheter 100” is not limited to the most distal end of the catheter 100, and the surgeon places the most distal end of the catheter 100 on the basis of the marker portion 120 under radioscopy.
  • an error within an allowable range is also included.
  • the tolerance of the position of the most distal end of the catheter 100 that is actually disposed with respect to the position where the distal end of the catheter 100 is to be disposed is set to about 0.1 mm to 0.8 mm.
  • the range from about 0.1 mm to 0.8 mm from the most distal end to the proximal end side of the catheter 100 is defined as “the most advanced”.
  • the permissible error is approximately the same as the thickness t1 (see FIG. 3) of the outer layer 115 of the shaft portion 110 that covers the marker portion 120 at the tip of the shaft portion 110.
  • the “tip portion of the catheter 100” means a range that substantially contributes to the flexibility required for any procedure of the catheter 100 and the followability along the shape of the living body lumen.
  • the distal end portion of the catheter 100 ranges from the aorta to the intrinsic hepatic artery, and is about 300 to 400 mm along the axial direction from the most distal end of the shaft portion 110. Means up to.
  • the shaft portion 110 is configured as a flexible tubular member extending in the axial direction and having a lumen 110a through which the guide wire GW can be inserted.
  • the tip portion 110d of the shaft portion 110 is disposed in the first region A1, and has a taper formed in a tapered shape with an outer diameter gradually decreasing toward the tip side (inclined with respect to the axial direction). It has a portion 111 and a constant outer diameter portion 112 that is disposed in the second region A2 on the proximal side of the tapered portion 111 and has a substantially constant outer diameter along the axial direction.
  • “having a substantially constant outer diameter along the axial direction” is not limited to having the physically same outer diameter. As long as the rigidity (bending rigidity and torsional rigidity) of the constant outer diameter portion 112 of the shaft portion 110 can be made substantially constant, it is only necessary to have a substantially constant outer diameter dimension.
  • the tapered portion 111 has an axial cross-sectional shape that is inclined substantially linearly. That is, the inclination angle of the tapered portion 111 with respect to the axial direction of the tapered shape is constant along the axial direction.
  • the axial cross-sectional shape of the taper portion 111 is not limited to this, and for example, has an axial cross-sectional shape curved in a convex shape radially outward and an axial cross-sectional shape curved in a concave shape radially inward. It may be.
  • the tapered portion 111 When the inclination angle of the tapered portion 111 is made constant along the axial direction, the tapered portion 111 can be easily formed as compared with the case where the tapered angle is changed along the axial direction.
  • the tip of the tapered portion 111 has a rounded shape. Thereby, the risk of damaging the inner wall of the living body lumen can be reduced.
  • the preferred value of the length of the shaft portion 110 varies depending on the position and thickness of the blood vessel to be applied, but is set to about 700 mm to 2000 mm, for example.
  • the preferable value of the outer diameter (thickness) of the shaft portion 110 varies depending on the position and thickness of the blood vessel to be applied, but is set to about 0.4 mm to 2.8 mm, for example.
  • the preferable value of the inner diameter of the shaft portion 110 (the outer diameter of the lumen 110a) varies depending on the thickness of the guide wire GW to be inserted, the position of the blood vessel to be applied, the thickness, and the like. It is set to about 2.4 mm.
  • the shaft portion 110 includes a tubular inner layer 113, a reinforcing body 114 that is disposed on the proximal side of the portion where the contrast region A is formed, and is formed by braiding a wire, and a reinforcing body. 114 and an outer layer 115 arranged to cover the outer surface of the inner layer 113.
  • the inner layer 113 and the outer layer 115 are made of only a resin that does not contain a metal.
  • the distal end portion 110d of the shaft portion 110 corresponding to the contrast region A of the catheter 100 is configured with only the inner layer 113 and the outer layer 115 without the reinforcement body 114 being disposed. That is, the tip portion 110d of the shaft portion 110 is made of only resin.
  • the inner layer 113 has a substantially constant thickness along the axial direction.
  • the distal end portion of the outer layer 115 is formed in a tapered shape whose outer diameter gradually decreases from the proximal end side toward the forefront.
  • the tip of the outer layer 115 formed in the tapered shape constitutes a tapered portion 111.
  • Examples of the constituent material of the inner layer 113 include PTFE (polytetrafluoroethylene), PFA (tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer), FEP (tetrafluoroethylene-hexafluoropropylene copolymer), ETFE (ethylene).
  • a resin such as a fluorine-containing ethylenic polymer such as (tetrafluoroethylene copolymer), a polyamide such as nylon, or a polyamide elastomer such as nylon elastomer can be used.
  • PTFE polytetrafluoroethylene
  • PFA tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer
  • the reinforcing body 114 is configured in a mesh shape by braiding predetermined strands (wires) on the outer surface of the inner layer 113.
  • the reinforcing body 114 is formed over substantially the entire length excluding the distal end portion 110 d of the shaft portion 110 with respect to the longitudinal direction of the catheter 100.
  • the reinforcing body 114 is not limited to a mesh shape, and may be configured in a coil shape.
  • the strands constituting the reinforcing body 114 for example, metal strands, resin strands, or a combination of metal strands and resin strands can be used. From the viewpoint of the workability of the strands and the manufacturability of the reinforcing body 114, it is preferably a metal strand. From the viewpoint of flexibility, stretchability, and electrical insulation, the molten liquid crystal polymer is used as the inner core, and the flexibility is improved. A monofilament resin strand having a polymer as an outer layer is preferred.
  • metal strand examples include stainless steel, tungsten, copper, nickel, titanium, piano wire, cobalt-chromium alloy, nickel-titanium alloy (superelastic alloy), copper-zinc alloy, amorphous alloy, etc.
  • Various metal strands can be used.
  • the cross-sectional shape of the strands constituting the reinforcing body 114 is not particularly limited, for example, it can be formed in a substantially circular shape or a substantially rectangular shape. However, from the viewpoint of improving operability by increasing the density of the reinforcing bodies 114, the cross-sectional shape of the strands is preferably substantially rectangular.
  • Examples of the constituent material of the outer layer 115 include polyolefin (for example, polyethylene, polypropylene, polybutene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, ionomer, or a mixture of two or more thereof), polyvinyl chloride, and the like. And polymer materials such as polyamide, polyester, polyester elastomer, polyamide elastomer, polyurethane, polyurethane elastomer, polyimide, fluorine resin, or a mixture thereof.
  • the outer layer 115 may have a multilayer structure formed by stacking different resin materials. It is also possible to form a hydrophilic coat layer or the like by covering the outer surface of the outer layer 115 with a material made of a hydrophilic polymer.
  • the marker unit 120 is disposed on the tip side of the reinforcing body 114 and is embedded in the outer layer 115.
  • the marker portion 120 has a marker tip portion 121 and a marker base end portion 125 that is continuous with the base end of the marker tip portion 121 and has a constant outer diameter along the axial direction.
  • the marker distal end portion 121 is disposed on the tapered portion 111 of the shaft portion 110 corresponding to the first region A1 of the catheter 100, and the outermost end thereof is aligned from the proximal end side so as to follow the outer shape of the tapered portion 111 of the shaft portion 110. It is formed in a tapered shape in which the outer diameter gradually decreases (inclined with respect to the axial direction).
  • the marker distal end portion 121 has a notch portion 122 that is notched from the most distal end toward the proximal end side.
  • the portion that remains after being cut out by the cutout portion 122 forms a protruding portion 123 that protrudes toward the distal end side.
  • the length (width) W1 along the circumferential direction of the cutout portion 122 gradually decreases from the front end toward the base end side. That is, the protrusion 123 is formed in a triangular shape having a length (width) W2 that gradually increases in the circumferential direction from the most distal end toward the base end side. Thereby, since the protrusion part 123 does not have a part (constriction) which becomes sharply narrow, the intensity
  • the length W1 along the circumferential direction of the notch 122 at the tip of the marker 120 is preferably set to about 0.2 to 4.8 mm.
  • the base end part of the marker part 120 is comprised so that the length W1 along the circumferential direction of the notch part 122 may become smaller than a front-end
  • the length L11 of the notch 122 along the axial direction is not particularly limited, but is set to about 0.4 mm to 1.4 mm, for example.
  • the marker part 120 has a plurality of cutout parts 122 along the circumferential direction. If the number of the notches 122 is one, the flexibility of the distal end of the catheter 100 may be reduced depending on the size of the notches 122. Further, when the number of the notch portions 122 is one, the arrangement of the notch portions 122 becomes unbalanced in the circumferential direction of the marker portion 120. On the other hand, if the number of the notch portions 122 is excessively increased, the visibility of the marker tip portion 121 under radioscopy is reduced. From the above viewpoint, the number of the notches 122 is preferably 2 to 8, and more preferably 4.
  • the tip shape of the protrusion 123 is rounded and chamfered. Thereby, the risk of damaging the inner wall of the living body lumen can be reduced.
  • the marker base end portion 125 is formed in a cylindrical shape having an outer diameter substantially constant along the axial direction.
  • the marker base end portion 125 is disposed over the entire circumferential direction and axial direction of the outer diameter constant portion 112 of the shaft portion 110 corresponding to the second region A2 of the catheter 100.
  • the length L (L1 + L2) along the axial direction of the marker portion 120 is not particularly limited, but is set to, for example, about 0.5 mm to 1.5 mm.
  • the length L1 along the axial direction of the marker distal end portion 121 is a value similar to the length along the axial direction of the distal end portion 110d of the shaft portion 110 and the length along the axial direction of the contrast region A of the catheter 100. is there.
  • the thickness of the marker portion 120 is formed to be substantially constant and is not particularly limited, but is set to about 0.02 mm to 0.2 mm, for example.
  • the outer diameter of the marker portion 120 can be formed slightly smaller (similar to the outer diameter) of the shaft portion 110. By setting the above range, the volume (amount) of the marker unit 120 determined by the length, thickness, and outer diameter of the marker unit 120 is large enough to maintain visibility under radioscopy. Can be secured.
  • the length L1 of the marker tip 121 along the axial direction is not particularly limited, but is set to about 0.4 mm to 1.4 mm, for example.
  • the length L2 along the axial direction of the marker base end portion 125 is not particularly limited, but is set to, for example, about 0.1 mm to 1.1 mm.
  • the ratio (L1 / L2) of the length L1 along the axial direction of the marker distal end portion 121 to the length L2 along the axial direction of the marker proximal end portion 125 is set to about 1 to 14.
  • the marker portion 120 is made of a metal material having a radiopacity (X-ray contrast property) higher than that of the inner layer 113 and the outer layer 115.
  • radiopacity X-ray contrast property
  • the radiopaque metallic material include noble metals such as gold, platinum, tungsten, and alloys containing these (eg, platinum-iridium alloys).
  • the contrast region A has the first region A1 disposed in a certain range from the most advanced state, and the second region A2 disposed on the proximal side from the first region A1.
  • the first region A ⁇ b> 1 is configured by arranging the marker tip portion 121 of the marker portion 120 on the tapered portion 111 of the shaft portion 110.
  • the second region A ⁇ b> 2 is configured by arranging the marker base end portion 125 of the marker portion 120 in the constant outer diameter portion 112 of the shaft portion 110.
  • the portion of the catheter 100 where the notch 122 is disposed is made of only resin.
  • the marker base end portion 125 is disposed over the entire circumferential direction and the axial direction of the outer diameter constant portion 112 of the shaft portion 110.
  • the first region A1 is formed with a higher resin content per unit volume than the second region A2.
  • the catheter hub 130 is liquid-tightly attached to the proximal end portion of the shaft portion 110 with an adhesive or a fixture (not shown). As shown in FIG. 1, the catheter hub 130 has a main body portion 131 having a lumen and a pair of handle portions 132 formed so as to protrude from the side portions of the main body portion 131.
  • the catheter hub 130 functions as an insertion port for the guide wire GW into the lumen 110a of the shaft portion 110 and an injection port for a contrast medium, a drug solution, an embolic material, and the like.
  • the catheter hub 130 functions as a grip when operating the catheter 100.
  • the constituent material of the catheter hub 130 is, for example, a synthetic resin such as polycarbonate, polyolefin, styrene resin, polyamide, or polyester, stainless steel, aluminum, or aluminum alloy.
  • the polyolefin is, for example, polyethylene, polypropylene, ethylene-propylene copolymer.
  • the kink protector 135 can be formed of an elastic material provided so as to surround a part of the base end portion of the shaft portion 110.
  • the effect of the catheter 100 according to the embodiment will be described by comparing the catheter 100 according to the embodiment with the catheter 200 according to the comparison.
  • FIG. 6 is an enlarged side view showing the distal end portion of the catheter 200 according to the proportionality
  • FIG. 7 is a schematic view showing a state where the catheters 100 and 200 according to the embodiment and the proportionality are bent
  • FIG. FIG. 8 is a diagram showing a schematic configuration of an abutment test of the catheters 100 and 200
  • FIG. 8B is a diagram showing a state of the catheters 100 and 200 according to the embodiment and a comparison in the abutment test.
  • a cylindrical marker portion 220 is disposed in the outer diameter constant portion 112 on the proximal end side with respect to the tapered portion 111 of the shaft portion 110.
  • the marker portion 220 is disposed at a position spaced from the forefront of the shaft portion 110 toward the length proximal end side of L21.
  • the length L22 along the axial direction of the marker unit 220 is approximately the same as that of the marker unit 220 according to the present embodiment.
  • the marker portion 220 is disposed at a position spaced from the most distal end of the catheter 200 to the proximal end side like the catheter 200 related to the proportionality, the most distal position of the catheter 200 cannot be grasped under radioscopy. Further, for example, it may be possible to improve the state-of-the-art visibility of the catheter 200 by placing a resin containing a radiopaque powder on the distal side of the marker portion 220. However, the radiopaque powder Since the resin containing is lower in radiopacity than metal, the state-of-the-art visibility of the catheter 200 under radioscopy is reduced as compared with the case where the metal marker portion 120 is disposed.
  • the catheters 100 and 200 have relatively high rigidity at the portions where the marker portions 120 and 220 are disposed. Further, the shaft portion 110 of the catheters 100 and 200 is provided with a reinforcing body 114 and has a certain degree of rigidity. Therefore, as shown in FIG. 7, the proximal end is more than the portion where the marker portions 120 and 220 are disposed. It bends gently in a predetermined range B1 on the side. That is, the predetermined range B1 is a region that is a starting point of bending of the catheters 100 and 200. The region B1 that is the starting point of bending is the same size as the catheter 100 according to the embodiment and the catheter 200 according to the comparative example.
  • the region B1 serving as a starting point of bending is formed on the distal end side with respect to the catheter 200.
  • the abutment test is a method in which a portion separated by a predetermined distance (for example, 3 mm to 10 mm) from the most distal end of the catheter is fixed with a jig T1, and a predetermined measuring instrument is used. This is a test for measuring the maximum abutting resistance value (abutting load) when the distal end of the catheter is abutted against the silicone plate T2 at an abutting speed (for example, 5 to 100 mm / min).
  • a predetermined distance for example, 3 mm to 10 mm
  • the region B ⁇ b> 1 serving as a starting point of bending is formed on the distal side of the catheter 200 as compared to the catheter 200 according to the proportionality.
  • the distal end of the catheter is abutted against the plate T2
  • the distal end portion of the catheter 100 is more easily bent than the comparative catheter 200.
  • the abutment resistance of the catheter 100 is lower than that of the catheter 200 that is proportional to each other, so that the flexibility (easy to bend) of the distal end portion of the catheter 100 is increased.
  • the first region A1 of the catheter 100 is formed with a higher resin content per unit volume than the second region A2. For this reason, the collision energy when the catheter 100 is abutted against the plate T2 can be changed to the deformation energy of the resin. Since the resin absorbs the impact when the catheter 100 is abutted against the plate T2, it is possible to suppress an increase in abutting resistance and an increase in the rigidity of the distal end of the catheter 100 due to the marker portion 120 being arranged at the forefront. .
  • the catheter 100 is formed of a tubular shaft portion 110 having a distal end portion 110d formed of resin, and a metal that is disposed on the distal end portion 110d of the shaft portion 110 and has radiopacity. And a ring-shaped marker portion 120.
  • the distal end portion 110d of the shaft portion 110 is disposed on the proximal end side with respect to the tapered portion 111 that is formed in a tapered shape that includes the most distal end and the outer diameter of the shaft portion 110 tapers toward the distal end side, And a constant outer diameter portion 112 having a substantially constant outer diameter along the axial direction.
  • the marker part 120 has a marker tip part 121 arranged on the taper part 111 so as to follow the outer shape of the taper part 111, and a marker base end part 125 arranged on the constant outer diameter part 112.
  • tip part 121 is formed with the resin content rate per unit volume higher than 2nd area
  • the catheter 100 since the distal end portion 110d of the shaft portion 110 has the tapered portion 111, the insertion property of the catheter 100 into the living body lumen can be improved.
  • the marker tip 121 is arranged so as to follow the outer shape of the tapered portion 111, the most advanced position of the catheter 100 can be grasped more accurately by observing the marker 120 under radioscopy. Can do.
  • the first region A1 is formed with a higher resin content per unit volume than the second region A2, the most advanced rigidity of the catheter 100 can be reduced.
  • the marker part 120 can be arrange
  • the bendability (flexibility) of the distal end portion of the catheter 100 can be improved. Therefore, according to the catheter 100, it is possible to improve the state-of-the-art visibility of the catheter 100 under radioscopy while ensuring the safety of the catheter 100.
  • the marker distal end 121 has a notch 122 that is notched from the leading edge toward the proximal end.
  • the portion where the cutout portion 122 is disposed is made of only resin. For this reason, the softness
  • the notch 122 has a length W1 that gradually decreases in the circumferential direction from the most distal end toward the base end side.
  • the protrusion part 123 which is a part left by being cut out by the notch part 122 is formed in a triangular shape in which the length W2 along the circumferential direction gradually increases from the front end toward the base end side. Therefore, the strength of the marker tip 121 can be maintained because the protrusion 123 does not have a portion (necking) that sharply narrows.
  • the marker tip 121 has a plurality of notches 122 along the circumferential direction, the flexibility of the tip of the catheter 100 can be improved.
  • FIG. 9 is a side view of the marker unit 320 according to the first modification.
  • the marker portion 320 is continuous with the marker distal end portion 321 and the proximal end of the marker distal end portion 321 and has a marker proximal end portion having a constant outer diameter along the axial direction. 325.
  • the marker tip 321 has a notch 322 and a protrusion 323.
  • the marker portion 320 according to the modified example 1 is different from the above-described embodiment in that the shape of the protruding portion 323 is U-shaped.
  • the notch 322 has a length W21 that gradually decreases in the circumferential direction from the most distal end toward the base end side, as in the above-described embodiment.
  • FIG. 10 is a side view of the marker unit 420 according to the second modification.
  • the marker portion 420 according to the modified example 2 is continuous with the marker distal end portion 421 and the proximal end of the marker distal end portion 421, and has a marker proximal end portion having a constant outer diameter along the axial direction. 425.
  • the marker tip 421 has a notch 422.
  • the marker unit 420 according to the modified example 2 includes a plurality of cutout portions 422 along the circumferential direction, and at least two cutout portions 422 among the plurality of cutout portions 422 are
  • the present embodiment is different from the above-described embodiment in that it has different shapes.
  • FIG. 11A is a side view of the marker portion 520 according to the modification 3
  • FIG. 11B is an axial sectional view of the marker portion 520.
  • the marker portion 520 according to the modification 3 is continuous with the marker distal end portion 521 and the proximal end of the marker distal end portion 521, and has a marker proximal end portion having a constant outer diameter along the axial direction. 525.
  • the marker part 520 according to the modification 3 is different from the above-described embodiment in that it does not have a notch part.
  • the thickness t52 of the marker base end portion 525 is formed to be substantially constant along the axial direction.
  • a thickness t51 of the marker distal end portion 521 is formed so as to gradually decrease from the distal end of the marker base end portion 525 toward the distal end side. That is, the thicknesses t51 and t52 of the marker portion 520 are formed so as to decrease from the proximal end toward the distal end.
  • the first region A1 where the marker distal end portion 521 is disposed in the catheter can be formed with a higher resin content per unit volume than the second region A2 where the marker proximal end portion 525 is disposed.
  • the thicknesses t51 and t52 of the marker portion 520 are formed so as to decrease from the proximal end toward the distal end. For this reason, when the marker part 520 is arrange
  • the shape of the marker portion is not limited to the above-described embodiment or modification as long as the first region can be formed with a higher resin content per unit volume than the second region.
  • the shape of the distal end portion of the protruding portion 123 is not limited to the above.
  • the shape of the notched portion 622 of the marker portion 620 may be a quadrangle.
  • the lengths W31 and W41 along the circumferential direction of the cutout portions 822 and 922 of the marker portion 820 have portions that gradually decrease from the base end side toward the forefront. Also good.
  • the tips of the protruding portions 823 and 923 of the marker portions 820 and 920 may have a flat shape in the direction perpendicular to the axis.
  • the tip of the protruding portion 123a of the marker portion 120a is curved in an arc shape radially inward so as to follow the outer shape of the tapered portion of the shaft portion (broken line in FIG. 16). May be included). Thereby, the risk of damaging the inner wall of the living body lumen can be greatly reduced.
  • the microcatheter has been described as an example.
  • the present invention is not limited to this.
  • the present invention can be applied to systems, contrast catheters, ultrasonic catheters, atherectomy catheters, endoscope catheters, drug solution administration catheters, and the like.
  • 100 catheters, 110 shaft part, 110d The tip of the shaft part, 111 taper part, 112 constant outer diameter part, 113 Inner layer, 114 reinforcements, 115 outer layer, 120, 320, 420, 520, 620, 720, 820, 920 marker part, 121, 521 Marker tip, 122, 322, 422, 522, 622, 722, 822 Notch, 123, 623, 723, 823, 923 protrusion, 125, 525 marker proximal end, 130 catheter hub, 200 paired catheters, 220, a marker part that is proportional, A contrast area, A1 first region, A2 second region, L Length along the axial direction of the marker part (L1 + L2), Length along the axial direction of the L1 marker tip, Length along the axial direction of the L2 marker base end, W1, W21, W31, W41 Length along the circumferential direction of the notch, W2 Length along the circumferential direction of the protru

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Le problème décrit par la présente invention est de fournir un cathéter, la visibilité de l'extrémité la plus distale du cathéter sous radioscopie pouvant être améliorée tout en assurant la sûreté du cathéter. La solution selon l'invention porte sur un cathéter 100 qui comprend : une partie d'arbre tubulaire 110 ayant une partie terminale 110d formée d'une résine ; et une partie de marqueur annulaire 120 disposée au niveau de la partie terminale de la partie d'arbre et formée d'un métal radio-opaque. La partie terminale de la partie d'arbre comprend : une partie conique 111 ; et une partie de diamètre externe constant disposée plus près du côté d'extrémité de base que la partie conique. La partie de marqueur a : une partie terminale de marqueur 121 disposée sur la partie conique de façon à suivre la forme externe de la partie conique ; et une section d'extrémité de base de marqueur 125 disposée sur la partie de diamètre externe constant. Une première région A1, qui est formée par la partie conique et la partie terminale de marqueur, a une teneur en résine plus élevée par unité de volume qu'une seconde région A2, qui est formée par la partie de diamètre externe constant et la section d'extrémité de base de marqueur.
PCT/JP2017/045986 2017-03-07 2017-12-21 Cathéter WO2018163564A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-042988 2017-03-07
JP2017042988A JP2020072769A (ja) 2017-03-07 2017-03-07 カテーテル

Publications (1)

Publication Number Publication Date
WO2018163564A1 true WO2018163564A1 (fr) 2018-09-13

Family

ID=63448192

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/045986 WO2018163564A1 (fr) 2017-03-07 2017-12-21 Cathéter

Country Status (2)

Country Link
JP (1) JP2020072769A (fr)
WO (1) WO2018163564A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024161790A1 (fr) * 2023-01-30 2024-08-08 テルモ株式会社 Cathéter et système de cathéter

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024080003A1 (fr) * 2022-10-11 2024-04-18 テルモ株式会社 Cathéter et système de cathéter
WO2025064248A1 (fr) * 2023-09-18 2025-03-27 Stryker Corporation Cathéter présentant un dispositif de marquage et une pointe polymère

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3605750A (en) * 1969-04-07 1971-09-20 David S Sheridan X-ray tip catheter
JP2001190681A (ja) * 2000-01-12 2001-07-17 Terumo Corp カテーテル
JP2005329062A (ja) * 2004-05-20 2005-12-02 Terumo Corp イントロデューサーシース
JP2006034347A (ja) * 2004-07-22 2006-02-09 Kaneka Corp 医療用カテーテルチューブならびにその製造方法
JP3136848U (ja) * 2007-08-10 2007-11-08 川澄化学工業株式会社 マイクロカテーテル
JP2015506749A (ja) * 2012-01-12 2015-03-05 フィシェル イノベーションズ，エルエルシー 進入及び追跡用迅速交換拡張器を持つ頸動脈シース並びに使用方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3605750A (en) * 1969-04-07 1971-09-20 David S Sheridan X-ray tip catheter
JP2001190681A (ja) * 2000-01-12 2001-07-17 Terumo Corp カテーテル
JP2005329062A (ja) * 2004-05-20 2005-12-02 Terumo Corp イントロデューサーシース
JP2006034347A (ja) * 2004-07-22 2006-02-09 Kaneka Corp 医療用カテーテルチューブならびにその製造方法
JP3136848U (ja) * 2007-08-10 2007-11-08 川澄化学工業株式会社 マイクロカテーテル
JP2015506749A (ja) * 2012-01-12 2015-03-05 フィシェル イノベーションズ，エルエルシー 進入及び追跡用迅速交換拡張器を持つ頸動脈シース並びに使用方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024161790A1 (fr) * 2023-01-30 2024-08-08 テルモ株式会社 Cathéter et système de cathéter

Also Published As

Publication number Publication date
JP2020072769A (ja) 2020-05-14

Similar Documents

Publication Publication Date Title
US11918760B2 (en) Flexible tip catheter
JP5450432B2 (ja) 成形可能なチップを備えた長尺状医療用デバイス
JP6031608B2 (ja) ガイドエクステンションカテーテルおよびガイドエクステンションカテーテルシステム
EP1804882B1 (fr) Catheter a extremite distale preformee
JPWO2018181178A1 (ja) カテーテル組立体
US20180296795A1 (en) Balloon catheter and medical elongated body
EP3347079B1 (fr) Cathéter
JP6031087B2 (ja) バルーンカテーテル
JP2010088833A (ja) カテーテル
JP5164283B2 (ja) バルーンカテーテル
JP2015500058A (ja) 強化型の伸長医療機器および製造方法
EP3347078B1 (fr) Corps de cathéter en polymère, pourvu d'un renfort
WO2018163564A1 (fr) Cathéter
WO2020162287A1 (fr) Cathéter prolongé, et procédé de fabrication de celui-ci
WO2018181177A1 (fr) Fil de guidage
JP2012005704A (ja) バルーンカテーテル
JP2012223207A (ja) バルーンカテーテル
US12156974B2 (en) Catheter and catheter assembly
JP2011125737A (ja) カテーテル
JP2006271901A (ja) コイル状造影マーカーとその製造方法、及びカテーテル
JP2007202979A (ja) 医療用ガイディングカテーテルチューブ
JP2018108119A (ja) ガイドワイヤおよび医療用コイル
JP2017063825A (ja) カテーテルデバイス
JP2016154631A (ja) カテーテル
WO2024157689A1 (fr) Ensemble cathéter et cathéter

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17899675

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17899675

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载